BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 7906055)

  • 21. Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats.
    Taksande BG; Kotagale NR; Patel MR; Shelkar GP; Ugale RR; Chopde CT
    Eur J Pharmacol; 2010 Jul; 637(1-3):89-101. PubMed ID: 20394743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonidine-displacing substance and its putative role in control of insulin secretion: a minireview.
    Chan SL
    Gen Pharmacol; 1998 Oct; 31(4):525-9. PubMed ID: 9792210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agmatine: an endogenous ligand at imidazoline receptors may be a novel neurotransmitter in brain.
    Reis DJ; Regunathan S
    J Auton Nerv Syst; 1998 Oct; 72(2-3):80-5. PubMed ID: 9851555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular effects of agmatine within the rostral ventrolateral medulla are similar to those of clonidine in anesthetized rats.
    Yang J; Wang WZ; Shen FM; Su DF
    Exp Brain Res; 2005 Jan; 160(4):467-72. PubMed ID: 15480603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptors.
    Pinthong D; Wright IK; Hanmer C; Millns P; Mason R; Kendall DA; Wilson VG
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Jan; 351(1):10-6. PubMed ID: 7715734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependence.
    Wu N; Su RB; Li J
    Cell Mol Neurobiol; 2008 Aug; 28(5):629-41. PubMed ID: 17653850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imidazole receptors and clonidine-displacing substance in relationship to control of blood pressure, neuroprotection, and adrenomedullary secretion.
    Reis DJ; Regunathan S; Meeley MP
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):51S-57S. PubMed ID: 1596395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine.
    Taksande BG; Kotagale NR; Tripathi SJ; Ugale RR; Chopde CT
    Neuropharmacology; 2009 Sep; 57(4):415-24. PubMed ID: 19589348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agmatine inhibits arginine vasopressin-stimulated urea transport in the rat inner medullary collecting duct.
    Rouch AJ; Kudo LH
    Kidney Int; 2002 Dec; 62(6):2101-8. PubMed ID: 12427134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is imidazoline site a unique receptor? A correlation with clonidine-displacing substance activity.
    Atlas D; Diamant S; Zonnenschein R
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):83S-90S. PubMed ID: 1317715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imidazoline binding sites on PC12 cells and bovine chromaffin cells.
    Steffen G; Dendorfer A; Dominiak P
    Ann N Y Acad Sci; 1995 Jul; 763():157-62. PubMed ID: 7677325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of an endogenous clonidine-displacing substance from rat brain.
    Atlas D; Burstein Y
    FEBS Lett; 1984 May; 170(2):387-90. PubMed ID: 6327389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinal and supraspinal agmatine activate different receptors to enhance spinal morphine antinociception.
    Roerig SC
    Ann N Y Acad Sci; 2003 Dec; 1009():116-26. PubMed ID: 15028575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B.
    King PR; Gundlach AL; Louis WJ
    Ann N Y Acad Sci; 1999 Jun; 881():161-70. PubMed ID: 10415911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of phenylethanolamine N-methyltransferase gene expression by imidazoline receptors in adrenal chromaffin cells.
    Evinger MJ; Ernsberger P; Regunathan S; Reis DJ
    J Neurochem; 1995 Sep; 65(3):988-97. PubMed ID: 7643129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation.
    Regunathan S; Youngson C; Raasch W; Wang H; Reis DJ
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1272-82. PubMed ID: 8786560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of imidazoline receptors and agmatine to psychiatry: a decade of progress.
    Halaris A; Piletz JE
    Ann N Y Acad Sci; 2003 Dec; 1009():1-20. PubMed ID: 15028565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An antiserum to idazoxan recognizes an immunoreactive substance in human serum and cerebral spinal fluid which is not agmatine.
    Wang H; Regunathan S; McGowan D; Bramwell S; Reis DJ
    Neurochem Int; 1997 Jan; 30(1):85-94. PubMed ID: 9116591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
    Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of [3H]p-aminoclonidine to two sites, alpha 2-adrenoceptors and imidazoline binding sites: distribution of imidazoline binding sites in rat brain.
    Kamisaki Y; Ishikawa T; Takao Y; Omodani H; Kuno N; Itoh T
    Brain Res; 1990 Apr; 514(1):15-21. PubMed ID: 2162708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.